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Vaccine Education and Compliance Statistics around the Greater Indianapolis Area
Matthew Budi, Phann.D. candidate; Veronica N. Vernon, Phann.D., BCPS BCACP', ,
Chad Knoderer, Phann.D.
Background: Recently, rates of certain vaccine-preventable diseases have increased and
outbreaks have occurred. For example, in 2014, the incidence of measles in the United
States reached a record high since 2000, with 644 total cases reported to the Centers for
Disease Control and Prevention's (CDC's) National Center for Immunization and
Respiratory Diseases. Increases such as this may likely be due to widespread public fears
that vaccines can cause serious adv~rse eveI~ts.Therefore, .due to their accessibility,
pharmacists can playa crucial role in lessenmg these public fears through proper
education.
Study objective: The primary objective of this study was to dispel rumors of vaccination
and educate the Indianapolis public about the benefits of receiving vaccines. The
secondary objective was to assess knowledge of and compliance to certain vaccines
among different subpopulations to determine susceptible groups. Barriers to receiving
vaccines were examined then analyzed.
Methods: A blinded interactive survey, available online from October 20,2014 to
January 12,2015, was used to meet the study obj.ectives. It was open for persons aged 18
years or older to respond at their will after watchmg a~ edu~ational video also posted
online. Vaccination rates, knowledge of personal vaccine history, and responses as to
why subjects were not up-to-date with their vaccines were collected. These descriptive
statistics were then analyzed to detennine trends among these groups.
Results: Fifty responses were collected. The population contained thirty-four females
and sixteen males, and age groupS ranged from 18-~9 years to 60-64 years. After taking
an educational survey, thirty-six subjects (72%) claimed that they were up-to-date with
their recommended vaccines, one person (~%)was not sure ifhe was up-to-date or going
to seek vaccination and twelve (24%) subjects were not up-to-date with their
recommended vac;ines. Of these twelve subjects, nine (75%) were not interested in
seeking vaccination, and three (25%) stated that they ~ere inte.rested in determining if
they needed to receive vaccines. All three oft~ese subJe~ts claimed that the educational
survey aided in their decision to seek vaccin~t~on. The.nl11esUb)ects not interested in
seeking vaccination had relatively strong opll1l0ns agal11stvaccmes.
Conclusion: Despite the small nU111be.rof respondents, this survey shows trends that may
be consistent with the general populatIOn. AI.lrespondents who were unsure or knowingly
not up-to-date with their recommended vaccmes and also ?pe~1to receiving vaccination
stated that the educational survey inspired them to detennll1e If further vaccination is
needed. On the other hand, all respondents who were unsur~ ~r knowingly not up-to-date
with their recommended vaccines and also not.op.en to rece.IVll1gvaccines were avidly
anti-vaccine. This study shoWSthat a phannacIs.t ISable to ll1flu~nce a substantial portion
of the population who is open to receiving vaccme.s. H~wever, for those who have strong
predisposed biases against vaccination, a phannac1st's mfluence may likely hold less
meri t.
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BACKGROUND
Vaccine-preventable diseases that lead to death or hospitalization create an unnecessary
public health burden in the United States. Approximately 50000 adults in the United
States die from vaccine-preventable diseases or complications from these diseases each
year. 1 Pharmacists can be advocates for vaccination in more ways than just
administration. As pharmacists can readily provide patient education, consultation,
vaccine referral to other healthcare providers, and vaccine administration, the role of a
pharmacist in vaccine administration is more crucial now than it has ever been. However,
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despite pharmacists' availability to the general public, rates of certain vaccine-
preventable diseases have increased and outbreaks have occurred. In 2012,48277 cases
of pertussis and 20 pertussis-related deaths were reported to the Centers for Disease
Control and Prevention (CDC).2 By comparison, in 2011, 15216 cases were reported.' In
addition, influenza and pneumonia, two diseases that are largely preventable through
vaccination, are the eighth leading cause of death in the United States. 1 Despite the high
incidence and severity of these diseases, vaccination rates for pneumococcal disease and
influenza have fallen below the Healthy People 2020 goal of90% established by the U.S.
Department of Health and Human Services.' Approximately 20% of adults 60 years and
older have reported receiving the shingles vaccine, and recent outbreaks of measles and
mumps reported from 2012 to February 2015 indicates an increasing need for vaccination
awareness and education for multiple vaccines.Y Due to the relative ease of international
travel, people residing in the United States need to maintain continued adherence in
keeping an up-dated immunization record, as several vaccine-preventable diseases are
endemic in other regions of the world.
NEED FOR THE STUDY
With recent rumors and myths of the high incidence and severity of the adverse effects
associated with vaccines, fewer people are seeking immunization, Unfortunately, despite
numerous studies refuting claims that vaccines cause these adverse effects, many people
still believe these claims to be tnle,6 This lack of vaccine adherence makes individuals
vulnerable to contracting vaccine-preventable diseases, and it also exposes other
susceptible persons. This study will focuS on the following vaccine-preventable diseases:
Influenza
According to the CDC, 2013-2014 influenza vaccination data shows that only about
42.2% of adults 18 years of age and older were vaccinated. Upon further examination, the
lowest reported rate of vaccination within the adult population was adults 18-49 years of
age, only achieving a 32.3% vaccination rate. With increasing age, the reported rate of
vaccination increased, with adults 65 years and older reporting a vaccination rate of
65%7 Furthenno
re
with the somewhat recent 2009 H IN I epidemic, the CDC estimates
,
that 43 million to 89 million people were infected in the United States, and the outbreak
caused up to 18300 deaths,S
Pertussis
Of the 20 pertussis-related deaths that were reported to CDC in 20 12, most occurred in
infan ts Iess than 3 months of age. The CDC reports that "As of December 3 I, 28660
cases of pertuss is were reported to CDC during 20 14, and this number is expected to
, 'I d,,2
Increase as case counts are reconc1 e '
Pneumococcal Disease
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Pneumococcal disease can be quite common and devastating. Streptococcus pneumoniae
accounts for one-third of all community-acquired pneumonia cases and one-half of all
hospital-acquired pneumonia cases.8 On average, about 175000 hospitalizations occur in
complication from pneumococcal pneumonia in the United States each year.
Furthermore, infection from StreptocOccuspneumoniae is a common complication of
influenza and measles infection, and it carries a 5-7% fatality rate, with increasing
incidence in the elderly. Additionally, pneumococcal "bacteremia occurs in about 25%-
30% of patients with pneumococcal pneumonia," and the fatality risk of pneumococcal
bacteremia ranges from 20% to 60%, again with increased risk in the elderly." Overall in
2009,5000 deaths from StreptotocCus pneurnoniae were reported.' Since pneumococcal
disease can arise as a complication of other vaccine-preventable diseases, this showcases
the importance of maintaining an up-to-date vaccination profile for all immunizations
across the board.
Measles
Prior to the advent of the measles vaccine, nearly every person in the United States
became infected with measles, and the incidence of the disease was about 500000 new
cases each year. With routine vaccine administration, incidence declined to its lowest
point of 37 new cases in 2004. However, due to the lack of measles vaccination in certain
areas, many individuals are still vulnerable to the virus, as evident in the measles
outbreaks that have occurred in recent years.
8
The CDC reports that "Pockets of
unvaccinated people can [even] exist in states with high vaccination coverage,
underscoring considerable measles susceptibility at some local levels ..,,10 This further
showcases that, in a world in which intemational travel can be done with relative ease,
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continued vaccine adherence is crucial in maintaining low incidence of vaccine-
preventable disease outbreaks.
Mumps
A few hundred people in the United States are reported to contract the mumps virus each
year. Before advent of the mumps vaccine, about 186000 new cases of mumps were
reported yearly in the United States. This decline in the rate of development of mumps
represents a more than 99% decrease in incidence. However, in recent years, mumps
outbreaks have occurred. A major risk factor that can predispose susceptible individuals
to the mumps virus is residing in a crowded environment. This is why outbreaks have
occurred on several college campuses. According to the CDC, in 2014, 1151 people in
the United States have been reported to have mumps. This is almost three-times higher
than the reported incidence of 438 people in 2013.
11
Rubella
According to the CDC, the incidence of rubella disease in the United States was less than
10 persons per year from 2009 to 2011? Though rubella disease should not be
disregarded, because of the relatively low incidence reported in this time period, this
vaccine-preventable disease will not be discussed. However, it should be noted that
immunity to the rubella virus is imparted through receipt of the MMR vaccine, which is
currently the only vaccine available to provide coverage against the measles and mumps
viruses.
Herpes Zoster (shingles)
According to the CDC, approximately 99.5% of people 40 years of age and older who
have been bom in the United States have been infected with wild-type varicella virus.
]lao\.? 16
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population, as the CDC reports that "There are an estimated one million cases of herpes
zoster in the United States annually." Additional risk factors that can contribute to
susceptibility of zoster infection may be addition of medications that suppress the
Because the rate of reactivation of the wild-type varicella virus is more common than the
attenuated virus in the vaccine, all persons older than 40 years of age in the United States
are at risk of developing herpes zoster, especially as their age increases. It appears that a
person's risk for development of herpes zoster increases as varicella cell-mediated
immunity declines. This decline in immunity may result from increasing age, which is
evident in comparing the overall incidence of zoster infection (0.4%) to its incidence in
persons aged 60 years and older (I%). Though the absolute incidence of infection is
relatively low, the relative rate of increase is more than double. Furthennore, incidence of
infection is rather high when examining numbers across the entire United States
immune system andlor increasing numbers of medical conditions, both of which are more
likely to occur with increasing age." With reported vaccine compliance of only 20.1% in
adults aged": 60 years in 2012, it is important to advertise the benefit of vaccination to
eligible individuals.!3
OBJECTIVE
The primary objective of this study was to educate the public around the greater
Indianapolis area of the benefits of being adherent to vaccination against pertussis,
influenza, pneumococcal disease, shingles, measles, and mumps. The secondary
obj ecti ve 0f this study was to detennine know ledge of and comp lian ce to the vaccines
examined between different subpopnlations to detennine susceptible groups.
METHODS
P '1 (l , I 7c b l,
Data Source
This study utilized a cross-sectional design. Itwas conducted via an interactive online
survey system, called SurveyMonkey. The study was advertised through online messages
sent to the Butler University community from the Butler University PR department and
also via email to students enrolled in the Butler University College of Pharmacy and
Health Sciences. Despite advertisement to only the Butler University community, the
survey was open to the general public from October 20,2014 to January 12,2015.
Respondents within 50 miles of the greater Indianapolis area were asked to take the
survey after watching an educational video posted online, at YouTube.com. The
population was encouraged to respond, as the survey questions were designed to
simultaneously educate them on vaccines that they were eligible for receiving. The data
collected was deidentified. If respondents knew they did not receive particular vaccines
or if they were unsure of they received a particular vaccine, they were asked if they were
interested in seeking or asking about receipt of those vaccines. For persons resistant to
receiving vaccines, variables that posed as barriers to vaccination were examined.
Study Population
The population surveyed consisted of individuals 18 years of age and older that resided
within a 50 mile radius of the greater Indianapolis area. Participants meeting these criteria
were asked to take the survey after they watched an educational video online. The
population contained thirty-four (68%) females and sixteen (32%) males. Forty (80%)
participants were aged 18-29 years, one (2%) participant was aged 30-34 years, three
(6%) participants were aged 40-44 years, one (2%) participant was aged 45-49 years, two
(4%) participants were aged 50-54 years, one (2%) participant was aged 55-59 years, and
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2 (4%) participants were aged 60-64 years. Thirteen (26%) respondents reported having
Master's Degree 1 (2)
received advanced graduate training, a PhD, or another professional degree (PharmO,
MD, 10, etc.), one (2%) respondent reported receiving a master's degree, seven (14%)
respondents reported receiving a bachelor's degree, 25 (50%) respondents reported
receiving some college education, an associate's degree, or trade school education, and
four (8%) respondents reported completing high school or receiving a OED as their
highest level of education.
1~~~MluJ(ibR::i!ntM;%'::mA
Female 34 (68)
Male 15 (32)
g.-' • '> ;--', •. ,,'J 'j , •. _,".. '
ttmtMttrtM t·&\fwg1lmIj:·'®Ma
1S-29 40 (SO)
30-34 1 (2)
Advanced Graduate
Training (PharmD, MD,
JD, etc.)
13 (25)
40-44 3 (5)
45-49 1 (2)
50-54 2 (4)
55-59 1 (2)
50-54 2 (4)
Bachelor's Degree 7 (14)
Some College, Associate's
Degree, Trade School 25(50)
High School, GED 4 (S)
Fig.l Basic respondent demographic data
Exclusion Criteria
To avoid skewed results and inaccurate data, the following subpopulations were excluded
from the study:
• Respondents who did not watch the educational video
• Persons diagnosed with asplenia or who had spleen problems
• Persons diagnosed with sickle cell disease
• Persons diagnosed with memory impairment or who had memory problems
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prevent them from receiving any preparation of that particular vaccine
These criteria were disclosed to each respondent in a pre-survey disclaimer, found in
Appendix.A.
Study Design
A blinded, interactive, cross-sectional survey was used to meet the study objectives. The
survey was availabl e online from October 20, 2014 to January 12, 2015. After watch ing
an educational video posted online, tile cohort responded to this survey online. The
survey contained 26 questions, which assesSbasic respondent demographics, including
age, education level, sex, and concomitant disease states. Based on answers to previous
demographic questions, respondents were then directed only to the vaccines they were
indicated to receive.
Measurement of Variables
•
Persons who considered themselves as 'immunosuppressed' or who were on
immunosuppressant medications at certain doses that would make them
immunosuppressed
Persons younger than 18 years of age
Persons enrolled in a prison
Persons who felt dependent on alcohol or illegal drugs to function with daily
activities
Persons who lived more than 50 miles outside of the greater Indianapolis area
Persons with a known allergy to a vaccine or a component of it, which would
•
•
•
•
•
• Dependent
o
Adherence to the vaccines listed in the survey
Pngc ItO
-• If non-compliant or unsure of compliance:
• Ask about the desire to receive vaccination or learn more
about vaccination
o For people who responded positively:
Pngc It 1
• Efficacy of the survey/educational video in
prompting respondents to do so
o For people who responded negatively or 'not sure'
• What would need to change to make these
persons want to receive indicated vaccines
[free-response text]
• Independent
o Sex
o Age range
o Highest education level
Statistical Analysis
Study groups were created based the independent variables. Vaccination rates, knowledge
of personal vaccine history, the desire to seek future vaccination for people who were not
up-to-date or not sure about vaccine status, and responses as to why certain people did
not want to seed future vaccination were collected. These descriptive statistics were then
analyzed, compared, and contrasted to determine trends within and among the subgroups.
The program utilized to determine these analyses was the Statistical Package for Social
Sciences version 13.0 (SPSS Inc., Chicago, IL). Post-assessment, barriers to receiving
vaccines were examined then analyzed.
RESULTS
Overall compliance
Fifty responses were collected from October 20,2014 to January 12,2015. The
population contained thirty-four females and sixteen males, and age groups ranged from
18-29 years to 60-64 years. After taking an educational survey, thirty-six subjects (72%)
claimed that they were up-to-date with their recommended vaccines, one person (2%)
was not sure ifhe was up-to-date or going to seek vaccination, and twelve (24%) subjects
were not up-to-date with their recommended vaccines. Of these twelve subjects, nine
(75%) were not interested in seeking vaccination, and three (25%) stated that they were
interested in determining if they needed to receive vaccines. All three of these subjects
claimed that the educational survey aided in their decision to seek vaccination. The nine
subjects not interested in seeking vaccination had relatively strong opinions against
vaccines.
.. No, t~:lU::G r ~.~DV!IIl...It 1 :1M
up-te-cate -",ilb ;&.'1 I~ VIC:C~'5
thOlt I neod
a Uo ~de-n w .. rc:'J ~t.o.!',"Q
.,-a:dnol or I den'1 care
Fig 2. Overall assessment of vaccine compliance and desire to seek
vaccination (for persons who qualified)
Subgroup results: sex
Five (14.7%) of the thirty-four female respondents were not up-to-date and not interested
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in seeking further vaccination after completion of the survey. Furthermore, five (31.3%)
of the sixteen male respondents were not up-to-date and either unsure or not interested in
seeking further vaccination after completion of the survey. Alternatively, twenty-nine
(89.3%) of the thirty-four female respondents and eleven (68.7%) of the sixteen male
respondents were either up-to-date or interested in seeking vaccination after completion
of the study.
Subgroup results: age
Among all age groups represented in this study (except age 30-34 years), there was at
least one respondent in each group that did not want to seek vaccination. Distribution of
these responses was relatively equal among groups, with one or two individuals in per
age range. Furthermore, of the three total respondents that were not up-to-date with
vaccines but interested in seeking vaccination, two were aged 18-29 years and one was
aged 60-64 years.
Regarding compliance, thirty-five (87.5%) respondents in the 18-29 year age group, one
(100%) respondent in the 30-34 year age group, and one (33.3%) respondent in the 40-44
year age group reported being up-to-date with their vaccines. Though there were only six
total respondents in the composite age range of 45-64 years, none of these respondents
(0%) reported being up-to-date with their vaccines.
Subgroup results: education level
Of the thirteen total respondents who received advanced graduate education, two (15.4%)
persons were not up-to-date and not interested in seeking further vaccination. The one
respondent who reported receiving a master's education was also not up-to-date and not
interested in receiving vaccines in the future. Additionally, four (57.1%) of the seven
total respondents who received a bachelor's degree were not up-to-date and not interested
10 seeking vaccination. Of the twenty-five total respondents who reported receiving some
college education, an associate's degree, or trade school education, three (12%) reported
not being up-to-date and not interested in seeking further vaccination. For the four total
respondents who stated that their highest level of education was high school graduation
or receipt of a OED, all were either up_to-date or were interested in seeking further
vaccination.
Male
11 (68.7) Advanced Graduate
Female
29 (89.3) Training (PharmD, MD,
11 (84.6)
JD, etc.)
18-29
35 (87.5)
Master's Degree
0(0)
30-34
1 (100) Bachelor's Degree
3 (42.9)
40-44
1 (33.3)
45-49
0(0)
Some college, Associate's 22 (88)
50-54
0(0)
Degree, Trade School
55-59
0(0)
High school, GED
4 (100)
60-64
0(0)
Fig 3. sub_populations up-to-date or interested in seeking
further vaccination after the study.
Individual vaccine results: influenza
Of th fir d 1.. ty nine (78%) reported receiving or planning on
e I ty total respon ents, t 111 -
recei he i . (200/) reported not receiving or not wanting to
vmg t re mfluenza vacCll1e,ten 10
recei he i . d (2%) responded that he or she was unsure if he or
ive t re Influenza vaccme, an one
she was going to receive the influenza vaccine.
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Individual vaccine results: herpes zoster
Of the two respondents who were 60 years of age or older, one (50%) reported receiving
the herpes zoster vaccine, and one (50%) reported not receiving the vaccine.
Individual vaccine results: measles, mumps, and rubella (MMR)
There were six respondents who qualified for receiving only one adult dose of the MMR
vaccine. Of these six individuals, two (33.3%) reported receiving a dose ofMMR, and
four (66.7%) reported not being up-to-date with the MMR vaccine.
Of the forty respondents who qualified for receiving two adult doses of the MMR
vaccine, thirty-five (87.5%) reported being up-to-date. In contrast, two (5%) respondents
reported not being up-to-date, and three (7.5%) reported being unsure if they were up-to-
date with the MMR vaccine series.
Individual vaccine results: Tdap
Of the fifty total respondents for whom the Tdap vaccine was assessed, forty-three (86%)
reported receiving a dose of Tdap in adulthood, five (10%) reported not receiving a dose
ofTdap in adulthood, and two (4%) respondents reported that they were unsure of their
Tdap vaccine status.
Individual vaccine results: pneumococcal (PPSV23 and PCV13)
There were five total respondents who were eligible for receiving the pneumococcal
vaccine series in adulthood. Of these five respondents, one (20%) reported being up-to-
date with the series. Conversely, the other four (80%) respondents reported not being up-
to-date with the series.
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Herpes Zoster
MMR (i-dose, 2_doses, respectivelY)
Tdap
Pneumococcal
39 (78)
1 (50)
2 (33.3), 35 (87.5)
43 (86)
1 (20)
Influenza'"
• Reported receiving or planning on receiving the influenza vaccine
Fig 4. compliance to each individual vaccine, if eligible
DISCUSSION
Per the results of the study, it appears that females are more complaint with their vaccines
compared to males, as twenty-nine (89.3%) ofthe thirty-four female respondents and
only eleven (68.7%) ofthe sixteen male respondents were either up_to-date or interested
In seeking vaccination after completion of the study. Additionally, it appears that age
holds no' I. W' 1 1 'f 1corre anon to vaccine compliance. It 1 t 10 exceptton 0 t .ie 30-34 year age
bracket, each age group represented in the study had at least one individual who was not
up-to-date and not interested in seeking vaccination. It also appears that education level
holds n ' ' ,W' 1 I ti f 1 I' 1o correl ation to vaccm
e
comphance. It t 1eexcep Ion 0 t 10 11g 1 schoOIIGED
group, there was at least one respondent in each educational group who was not up-to-
date and not interested in seeking vaccination. Further, more controlled study with larger
populations is needed to determine if these differences are significant or not and if these
i/
results are comparable to CDC reports,
The two vaccines that reflected the entire study population were influenza and Tdap.
Thus, assessment of adherence rates with tbese tWOvaccines likely holds more power in
their results compared to the otber vaccines studied. Adherence between the two vaccines
was relatively similar: 86% of respondents reported being up_to-date with the Tdap
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vaccine, and 78<Y< f ..
o 0 respondents reported bemg up-to-date with the inlluenz
a
vaccine.
Similarly
, rates of non-adherence betweeo the (WO groups was simi lar, with 10% of the
study popul ti
a IOn not being compliant with Tdap and 20% of the study population not
being .
compliant or willing to receive the inlluenza vaccine. Of note, 4% of respondents
and 2% of ...respondents were unsure If they rec"ved or were going to receive the Tdap
and influ .enza vaccines, respectively.
For the MMR vaccine, forty-six total subjects assessed their compliance. Of these, only
six q rfi
ua I ted for receiving a one-time dose ofMMR in adulthood. A majority (66.7%) of
these si bi
x su jects were not up_to-date with the MMR vaccine. The remaining forty
respondents qualified for receiving two doses of the MMR vaccine in adulthood.
Compliance in this group was much higher, with 87.5% of subjects within this group
reporting being up-to-date. This likely could be a result of the advertisement of the
survey t f 1 d 11 S .o students in Butier University's College 0 p 1anna
c
y an Hea t 1 crences
program, which requires proof of immuni ty to the measles, mumps, and rubella viruses.
The herpes zoster and pneumonia vaccines had a relativelY small number of qualifying
respondents, so their results will not be discussed at length. However, it should be noted
that only one of the flve total respondents (20%) reported being up-tn~date witb the
pneumonia vaccine. This should be a primary area of interest for healthcare professionals,
as thi . . 11· 1 CDC'
ISmay likely be the case for the general population, especl
a
Ysmce t 1C s
pneumococcal vaccine recommendations were recently changed in 2014 for persons older
than 65 years of age.
To truly determine significance o[these results and ifthey are comparable to CDC
reports furthe t 11 d t dy wl·th larger populations is needed .
., r, more con ro e s u
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Study strengths
A primary strength of this study is that the geographic location of respondents was
relatively constant, being within 50 miles of the greater Indianapolis area. Additionally,
this study ensured that respondents were properly educated prior to and during
administration of the survey. With the questions guiding the subjects, they were only
navigated toward assessing vaccines that they were eligible for receiving.
Study limitations
One of the primary limitations of this study was that individuals only knew about the
study if they were exposed to internet media. Additionally, only those that were literate
(unless directed by a literate individual) were able to take the survey. Furthermore,
individuals that did not understand how to navigate through the survey were unable to
respond. Thus, this study likely underrepresents populations with a lower education level
and those who cannot or do not choose to have internet access or those who have
difficulty navigating the internet. Also, because minors were not included in the study,
trends of data for individuals less than 18 years of age were not reflected in the study
results. Therefore, this study may overlook causative factors for lack of vaccine
adherence that exist solely in these younger age groups.
Because this study was open to the general public, it could contain a relatively large
amount of selection bias. Whether positive or negative in opinion, people who had a high
amount interest in vaccines were probably more likely to respond, especially since the
survey required subjects to watch a six-minute video prior to responding. Furthen
nore
, as
the stu i d' 1ttl nts el11'olledin the Butler University College of
ey was a vertlsee 0 s uc e
Phar dIS . lection bias could have also occurred as a result of this.
rmacy an Healt 1 Clences, se
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Though the study examined certain independent variables that could influence a person's
compliance to vaccines, several other variables that could influence vaccine adherence
were not studied. Additionally, due to a small number of respondents, the independent
variables examined may not be indicative of trends within the general population.
CONCLUSION
Despite the small number of respondents, this survey shows trends that may be consistent
with the general population. All respondents who were unsure or knowingly not up-to-
date with their recommended vaccines and also open to receiving vaccination stated that
the educational surveyor video inspired them to determine if further vaccination is
needed. On the other hand, all respondents who were unsure or knowingly not up-to-date
with their recommended vaccines and also not open to receiving vaccines were avidly
anti-vaccine. This study shows that, for those who have strong predisposed biases against
vaccination, a phan11acist's influence may likely not hold much merit. However, this
study also shows that a pharmacist is able to influence a substantial portion of the
population who is open to receiving vaccines. With continued diligence in the realm of
vaccine practice, pharmacists can continue to solidify their position on the healthcare
team and push for provider status.
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APPENDIX.A: Survey Disclaimer
• The answers you give will be used to report vaccination trends in the greater
Indianapolis area for the Vaccine Education and Compliance Statistics around the
Greater Indianapolis Area research study. Your answering these questions means
that you give consent out of your own free choice without undue inducement.
o 1. Nature and Duration of Procedure
• The purpose of this study is to educate the public on the benefits of
getting vaccines and to dispel the false rumors of the bad effects of
vaccines. Additionally, this study will help the researchers learn
about your knowledge of your vaccination history and if you are
up-to-date in receiving certain vaccines. The study will also help
the researchers to identify barriers that prevent certain people from
receiving vaccines. Participation in this study is voluntary, but if
you choose to respond, you are required to watch an educational
video beforehand. A link to this video can be found on the survey
disclaimer. It should take about 10 minutes to complete the survey.
You will be mostly asked yes or no questions and other questions
that require clicking on a circle. You may encounter one question
that requires you to type a response. Generally, most questions
asked will regard your age, sex, education level, and your medical
lifestyle. If at any point in the survey response, you feel that you
are offended by a certain question or do not want to respond, you
have every right to exit out of the survey and choose not to
complete it. Your choosing to stop responding will in no way
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affect your relationship with the researchers or Butler University.
Upon stopping, your answers will not be saved and will be deleted.
If you choose to participate, your answers will be kept confidential
(anonymous) and cannot and will not be tracked back to you.
2. Potential Risks and Benefits
• There are no known risks or discomforts associated with this
research. There are also no known direct benefits of this research.
However, the data that you input will allow the researchers to
make decisions, improve their knowledge of, and identify trends
that can increase public health when it comes to vaccines.
o 3. Questions Concerning the Study
• If you have any questions regarding the study or any aspect of it,
please contact the thesis preceptor, Kena Lanham, at the following
address: 4600 Sunset Avenue Indianapolis, IN 46208. If you
desire to take the survey and agree to the Voluntary Willingness to
Participate Statement, please check the box below.
• Thank you very much for taking interest in responding to this survey! This survey
is designed to educate you about some commonly-received vaccines. The answers
you give will help report vaccination trends in the greater Indianapolis area.
Please note that by responding to this survey, you agree to the terms and
conditions found on the Voluntary Willingness to Participate Statement, which is
offered to you by checking the box below. As mentioned in the Voluntary
,,.,,.,
Willingness to Participate Statement, your answers are anonymous and cannot
and will not be tracked back to you.
o To report accurate information, please do NOT respond to this survey if
you:
• Have not yet watched the educational video, found at:
http://youtu.be/Fl_OJcVChpE
• Have been diagnosed with asplenia or have spleen problems
• Have been diagnosed with sickle cell disease
• Have been diagnosed with memory impainnent or have memory
problems
• Are considered 'immunosuppressed' or are on immunosuppressant
medications at certain doses that would make you
immunosuppressed
• Are younger than 18 years of age
• Are currently enrolled in a prison
• Feel dependent on alcohol or illegal drugs to function with daily
activities
• Live more than 50 miles outside of the greater Indianapolis area
• Have a known allergy to a vaccine or a component of it, which
would prevent you from receiving any preparation of that
particular vaccine
o Please check a box below if you are interested in taking the survey and/or
would like to view the Voluntary Willingness to Participate Statement.
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